his real goal is to invent new drugs for rare diseases. Turing recently announced discounts of Daraprim for hospitals, and Shkreli says that for people without insurance it will cost only $1 a pill. For everyone else, insurance, which he argues is paid for by corporate America’s profits, will cover the cost.
https://www.vanityfair.com/news/2015/12/martin-shkreli-pharmaceuticals-ceo-interview